Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume

Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 22,200,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 9.0. Learn More on Syndax Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Squarepoint Ops LLC, Nomura Holdings Inc., OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., JPMorgan Chase & Co., and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Syndax Pharmaceuticals saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 22,200,000 shares, a drop of 0.8% from the previous total of 22,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Syndax Pharmaceuticals: Grifols, S.A. (1.22%), TG Therapeutics, Inc. (19.30%), Krystal Biotech, Inc. (10.47%), SpringWorks Therapeutics, Inc. (19.36%), Biohaven Ltd. (9.34%), Recursion Pharmaceuticals, Inc. (19.74%), PTC Therapeutics, Inc. (5.39%), Organon & Co. (6.46%), Ultragenyx Pharmaceutical Inc. (4.51%), Alvotech (0.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading up $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is January, 31 2025.